Home / News / News & Updates / New COVID-19 Vaccine Recommendations for Cancer Patients New COVID-19 Vaccine Recommendations for Cancer Patients March 26, 2021 - The Ontario Vaccine Clinical Advisory Group (VCAG) released updated guidance on COVID-19 vaccines, recommending that the interval between the first and second dose should be as per manufacturer protocol for those with immunocompromising conditions and immunosuppressive therapies. This includes transplant patients and cancer patients on active treatment with chemotherapy, targeted therapies, and immunotherapy. Read the press release here. News News & Updates Current News February 2024 Newsletter In this Issue: Nova Scotia Screening Program Announced! Lung Ambition Awards Opportunity Listen to our Lung Cancer Voices Podcast Upcoming Events Read More November 2023 Newsletter In this issue: LCAM Activities November 2023 Newsletter Read More Questions To Ask Clinical Trials Share Your Story Community Activities Make A Donation Peer to Peer Network
Home / News / News & Updates / New COVID-19 Vaccine Recommendations for Cancer Patients New COVID-19 Vaccine Recommendations for Cancer Patients March 26, 2021 - The Ontario Vaccine Clinical Advisory Group (VCAG) released updated guidance on COVID-19 vaccines, recommending that the interval between the first and second dose should be as per manufacturer protocol for those with immunocompromising conditions and immunosuppressive therapies. This includes transplant patients and cancer patients on active treatment with chemotherapy, targeted therapies, and immunotherapy. Read the press release here. News News & Updates Current News February 2024 Newsletter In this Issue: Nova Scotia Screening Program Announced! Lung Ambition Awards Opportunity Listen to our Lung Cancer Voices Podcast Upcoming Events Read More November 2023 Newsletter In this issue: LCAM Activities November 2023 Newsletter Read More Questions To Ask Clinical Trials Share Your Story Community Activities Make A Donation Peer to Peer Network